We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Bench-Top Robotic Cell-Free DNA Extraction Workstation Automates NIPT Workflows

By LabMedica International staff writers
Posted on 06 Sep 2023
Print article
Image: The MagBench automated DNA extraction instrument (Photo courtesy of Yourgene Health)
Image: The MagBench automated DNA extraction instrument (Photo courtesy of Yourgene Health)

Yourgene Health (Manchester, UK) has launched the Yourgene MagBench Automated DNA Extraction Instrument and Kit, designed to provide clinical laboratories with an efficient and cost-effective bench-top robotic workstation for cell-free DNA (cfDNA) extraction. This system is specifically optimized for Yourgene's Sage 32 NIPT Workflow, offering a comprehensive end-to-end solution, from sample handling to generating reports. This integrated approach enables clinical laboratories to offer a more accurate and competitive non-invasive prenatal testing (NIPT) service.

The Sage Prenatal Screen, a key component of this workflow, facilitates the safe and accurate genetic assessment of placental DNA in maternal blood using next-generation sequencing, delivering results within three days. The NIPT workflow begins with the extraction of DNA from maternal plasma using the MagBench instrument. Subsequent steps include library preparation, enrichment, sequencing, and Sage Link analysis, which estimates the risk of fetal trisomy 21, 18, or 13, rare autosomal aneuploidies, sex chromosome aneuploidies, and clinically significant microdeletions.

The MagBench Automated DNA Extraction Instrument is user-friendly, quick to install, and features an intuitive touchscreen interface with pre-programmed protocols. It offers efficient run times and flexible sample throughput to meet the laboratory's testing requirements. The MagBench Extraction Kit includes sample and elution tubes, pre-sealed cartridges containing all necessary reagents for cfDNA purification, and individually packaged tip sets with a unique cross-notch design to ensure precise volume pipetting. This system enhances the automation of DNA extraction, reducing manual intervention and the risk of human error. Additionally, it incorporates single-use tip disposal and a built-in UV lamp for decontamination between runs, thereby minimizing the potential for cross-contamination. These features collectively contribute to improved pipetting accuracy and consistency, resulting in a reduced failure rate. The MagBench solution is available to Sage customers in the Asia-Pacific and Middle East regions.

“Yourgene is committed to delivering best-in-class NIPT solutions, where precision and quality assurance are key,” said Dr. Rob Henke, Vice President of Sales, Asia-Pacific at Yourgene Health. “MagBench enables an economical and automated NIPT workflow. Reducing manual procedures improves user experience, facilitating true walkaway time while minimizing the risk of contamination and improving testing accuracy. This decreases the number of screening failures, greatly improves efficiency, and helps lower expectant parents’ anxiety.”

Related Links:
Yourgene Health

New
Gold Member
ANCA IFA
Kallestad Autoimmune ANCA IFA Complete Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
hCG+β Automated Immunofluorescent Assay
B·R·A·H·M·S hCG+β KRYPTOR
New
Silver Member
Cytomegalovirus Test
ReQuest CMV IgM ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The new platelet-centric scoring system predicts platelet hyperreactivity and related risk of cardiovascular events (Photo courtesy of Shutterstock)

Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke

Platelets, which are cell fragments circulating in the blood, play a critical role in clot formation to stop bleeding. However, in some individuals, platelets can become "hyperreactive," leading to excessive... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
A schematic of the 3D MM imaging experimental setup used in the studies of blood films (Photo courtesy of Ushenko, A.G., et al.; doi.org/10.1038/s41598-024-63816-z)

Novel Light-Based Technique With 90% Accuracy Rate to Revolutionize Cancer Diagnosis

A quicker, cheaper, and less painful cancer detection technique developed using light has the potential to revolutionize cancer diagnosis, early detection, and monitoring. Researchers at Aston Institute... Read more

Industry

view channel
Image: The QIAstat-Dx IVD panel for neurodegenerative applications will be integrated with the QIAstat-Dx multiplex testing platform (Photo courtesy of QIAGEN)

Qiagen and Eli Lilly to Develop First QIAstat-Dx IVD Panel for Neurodegenerative Applications

QIAGEN N.V. (Venlo, the Netherlands) has entered into a collaboration with Eli Lilly and Company (Indianapolis, IN, USA) to support the development of a QIAstat-Dx in-vitro diagnostic (IVD) to detect APOE genotypes.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.